The University of Sheffield
Poster v3.pptx (1.27 MB)
Download file

Exhaled nitric oxide for the diagnosis of asthma in children and adults: a systematic review

Download (1.27 MB)
posted on 2020-03-20, 13:26 authored by Susan HarnanSusan Harnan, Munira EssatMunira Essat, Tim Gomersall, Paul TappendenPaul Tappenden, Ruth WongRuth Wong, R. Lawson, Ian Pavord, M. Everard
The fraction of exhaled nitric oxide (FeNO) is a marker of eosinophilic inflammation, which is associated with some forms of asthma. Asthma is currently diagnosed using a pathway of tests including spirometery, airway reversability (response to bronchodilator or course of inhaled corticosteroids (ICS)) and airway hyper-responsiveness (e.g. methocholine challenge). FeNO may be a useful diagnostic test in this pathway. This systematic review aimed to identify and synthsise evidence rating to the diagnostic accuracy of FeNO for asthma with a UK focus. We looked at the highest sum of sensitivity and specificity, as well as evidence about the potential for FeNO to be used as a rule-in test (high-specificity) or as a rule-out test (high-sensitivity).



  • There is no personal data or any that requires ethical approval


  • The data complies with the institution and funders' policies on access and sharing

Sharing and access restrictions

  • The data can be shared openly

Data description

  • The file formats are open or commonly used

Methodology, headings and units

  • Headings and units are explained in the files

Usage metrics

    School of Health and Related Research - HEDS